Advanced Search

    Technical Analysis for RUBY - Rubius Therapeutics Inc

    Grade Last Price % Change Price Change
    B 0.0215 8.04% 0.0016
    RUBY closed down 0.5 percent on Friday, March 17, 2023, on 67 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A N/A N/A
    Historical RUBY trend table...
    Date Alert Name Type % Chg
    Hot IPO Pullback Bullish Swing Setup 8.04%
    NR7 Range Contraction 8.04%
    Doji - Bullish? Reversal 8.04%
    New 52 Week Low Weakness 8.04%
    Hot IPO Pullback Bullish Swing Setup 7.50%
    New 52 Week Low Weakness 7.50%
    New 52 Week Closing Low Bearish 13.16%
    Hot IPO Pullback Bullish Swing Setup 13.16%
    New 52 Week Low Weakness 13.16%
    Down 3 Days in a Row Weakness 13.16%
    Older End-of-Day Signals for RUBY ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Down 5% about 1 hour ago
    Down 3% about 1 hour ago
    Up 5% about 1 hour ago
    Up 3% about 1 hour ago
    Gapped Down (Partial) about 1 hour ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators Basic chart:

    Profile

    Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
    Classification
    Keywords: Health Cancer Biopharmaceutical Diabetes Cancers Epidemiology Severe Diseases Human Papillomavirus Infection Rtx

    Is RUBY a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.0621
    52 Week Low 0.017
    Average Volume 2,129,340
    200-Day Moving Average 0.0000
    50-Day Moving Average 0.0000
    20-Day Moving Average 0.0000
    10-Day Moving Average 0.0000
    Average True Range 0.0000
    RSI 0.00
    ADX 0.0
    +DI 0.0000
    -DI 0.0000
    Chandelier Exit (Long, 3 ATRs) N/A
    Chandelier Exit (Short, 3 ATRs) N/A
    Upper Bollinger Bands 0.0000
    Lower Bollinger Band 0.0000
    Percent B (%b) 0.0
    BandWidth 0.0000
    MACD Line 0.0000
    MACD Signal Line 0.0000
    MACD Histogram 0.0
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.0267
    Resistance 3 (R3) 0.0264 0.0240 0.0255
    Resistance 2 (R2) 0.0240 0.0222 0.0241 0.0251
    Resistance 1 (R1) 0.0219 0.0212 0.0207 0.0222 0.0248
    Pivot Point 0.0195 0.0195 0.0189 0.0196 0.0195
    Support 1 (S1) 0.0174 0.0177 0.0162 0.0177 0.0150
    Support 2 (S2) 0.0150 0.0167 0.0151 0.0147
    Support 3 (S3) 0.0129 0.0150 0.0143
    Support 4 (S4) 0.0132